These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 3911152)
1. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration]. Mounier M; Benevent D; Denis F Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis. Whitby M; Edwards R; Aston E; Finch RG J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051 [TBL] [Abstract][Full Text] [Related]
3. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis. Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W Nephron; 1986; 43(3):217-22. PubMed ID: 3724930 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis. Tomino Y; Fukui M; Hamada C; Inoue S; Osada S Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717 [TBL] [Abstract][Full Text] [Related]
5. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. Mars RL; Moles K; Pope K; Hargrove P Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311 [TBL] [Abstract][Full Text] [Related]
6. Vancomycin therapy for gram-positive peritonitis in patients on CAPD. Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394 [TBL] [Abstract][Full Text] [Related]
7. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis]. Thomae U; Koblinger S Med Klin (Munich); 1994 Sep; 89(9):464-8. PubMed ID: 7968880 [TBL] [Abstract][Full Text] [Related]
8. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis]. Kostić S; Ljuvenović S; Velicković R; Stefanović V; Raicević R; Cukuranović R; Veljković S; Djordjević V; Malobabić Z Srp Arh Celok Lek; 1996; 124 Suppl 1():149-51. PubMed ID: 9102884 [TBL] [Abstract][Full Text] [Related]
9. Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients. Were AJ; Marsden A; Tooth A; Ramsden R; Mistry CD; Gokal R Clin Nephrol; 1992 Apr; 37(4):209-13. PubMed ID: 1582059 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics]. Denis F; Mounier M; Lagarde C; Benevent D Pathol Biol (Paris); 1987 May; 35(5):652-5. PubMed ID: 3302879 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942 [TBL] [Abstract][Full Text] [Related]
14. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie. Klaus G; Schaefer F; Müller-Wiefel D; Mehls O Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD. Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788 [TBL] [Abstract][Full Text] [Related]
17. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis. Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of peritonitis due to continuous ambulatory peritoneal dialysis using a single daily intraperitoneal dose of 1g cefotiam]. Ragnaud JM; Roche-Bezian MC; Marceau C; Demothes-Mainard F; Albin H; Prevost D; Wone C Pathol Biol (Paris); 1986 May; 34(5):512-6. PubMed ID: 3534734 [TBL] [Abstract][Full Text] [Related]
20. [Clinical assessment of CAPD (continuous ambulatory peritoneal dialysis) for chronic end-stage renal failure]. Ohira S; Abe K; Kon T Hokkaido Igaku Zasshi; 1984 Jul; 59(4):478-87. PubMed ID: 6386640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]